GO:0002943 tRNA dihydrouridine synthesis: RNA Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002943 (tRNA dihydrouridine synthesis) describes the enzymatic conversion of uridine to dihydrouridine (D) within transfer RNA molecules.
• Dihydrouridine is one of the most abundant post-transcriptional modifications in tRNA and is introduced by tRNA dihydrouridine synthases (DUS enzymes) that use NADPH as a reducing cofactor.
• DUS enzymes are conserved from bacteria to humans, but their number and substrate specificity vary widely across species, with some organisms undergoing reductive evolution of the pathway.
• Human DUS1L catalyzes dihydrouridylation at tRNA positions 16/17, and its overexpression perturbs global translation, linking the modification to translational control.
• Functional redundancy among DUS paralogs ensures robust dihydrouridylation, and the modification is sensitive to cellular redox status.
• Dysregulation of tRNA modifications, including dihydrouridine synthesis, is increasingly implicated in cancer, neurological disorders, and mitochondrial diseases.
Description
GO:0002943, tRNA dihydrouridine synthesis, is the biological process by which a uridine residue in a transfer RNA (tRNA) molecule is enzymatically converted to dihydrouridine (D). This modification is one of the most abundant and evolutionarily conserved post-transcriptional changes in tRNA, contributing to the structural stability and functional fidelity of the tRNA molecule. Dihydrouridine synthesis is catalyzed by tRNA dihydrouridine synthases (DUS), a family of flavin-dependent enzymes that reduce the C5-C6 double bond of uridine using NADPH as an electron donor. The resulting dihydrouridine residue is typically found in the D-loop of tRNA, where it influences the local RNA conformation and flexibility. Researchers study GO:0002943 because tRNA modifications are critical for translation efficiency and accuracy, and their dysregulation has been linked to a growing list of human diseases, including cancer and neurodevelopmental disorders. The dihydrouridine landscape extends beyond tRNA to mRNA, suggesting broader roles in RNA biology. Recent work has revealed that DUS enzymes exhibit differential sensitivity to cellular redox conditions, and that functional redundancy among DUS paralogs ensures robust modification. In humans, DUS1L specifically modifies tRNA positions 16/17, and its overexpression disrupts translation, highlighting the importance of precise regulation. Understanding the molecular players and regulatory mechanisms of tRNA dihydrouridine synthesis is therefore essential for both basic RNA biology and translational medicine.
tRNA dihydrouridine synthesis At A Glance
| GO ID | GO:0002943 |
|---|---|
| GO term | tRNA dihydrouridine synthesis |
| Ontology | biological_process |
| Synonym | None |
| Major function | Enzymatic conversion of uridine to dihydrouridine in tRNA |
| Cellular location | Cytoplasm (tRNA modification occurs primarily in the nucleus and cytoplasm) |
| Enzymes involved | tRNA dihydrouridine synthases (DUS1, DUS2, DUS3, DUS4 in yeast; DUS1L, DUS2, DUS3L, DUS4L in humans) |
| Cofactor | NADPH (reducing agent) |
| Representative species | Bacteria, yeast, humans; pathway is under reductive evolution in Mollicutes |
What Is GO:0002943?
GO:0002943 is defined as the process whereby a uridine in a transfer RNA is converted to dihydrouridine. In other words, it is the enzymatic reduction of uridine to dihydrouridine within tRNA molecules, a post-transcriptional modification that introduces a saturated pyrimidine ring. This process is carried out by tRNA dihydrouridine synthases (DUS) and requires reducing equivalents, typically from NADPH.
Why Is tRNA dihydrouridine synthesis Important in Cell Biology?
tRNA dihydrouridine synthesis is important because dihydrouridine is a key structural determinant of tRNA, affecting its folding, stability, and interaction with the translation machinery. The modification enhances the conformational flexibility of the D-loop, which is critical for tRNA function during protein synthesis. Disruption of dihydrouridine synthesis can lead to translational defects, and in humans, aberrant DUS1L expression perturbs global translation. Moreover, the sensitivity of DUS enzymes to redox conditions links this modification to cellular stress responses. Given the emerging roles of tRNA modifications in disease, understanding GO:0002943 provides insights into cancer, neurological disorders, and mitochondrial pathologies.
• Dihydrouridine is one of the most abundant tRNA modifications, essential for tRNA structure and function.
• DUS enzymes are conserved across all domains of life, but their redundancy and specificity vary, offering evolutionary insights.
• Human DUS1L modifies tRNA positions 16/17, and its overexpression disrupts translation, linking the modification to translational control.
• Redox sensitivity of DUS enzymes connects tRNA modification to cellular stress and metabolic states.
• Dihydrouridine synthesis is under reductive evolution in Mollicutes, providing a model for minimal tRNA modification systems.
• Dysregulation of tRNA modifications, including dihydrouridylation, is implicated in cancer and neurological diseases.
• The modification can be studied in vitro using thermophilic enzymes like Thermus thermophilus DUS, facilitating biochemical assays.
• Prebiotic synthesis of dihydrouridine suggests ancient origins of this modification, relevant to origin-of-life research.
• Functional redundancy among DUS paralogs ensures robustness, complicating genetic studies but revealing buffering mechanisms.
• Targeting DUS enzymes may offer therapeutic opportunities in diseases characterized by translational dysregulation.
What Happens During tRNA dihydrouridine synthesis?
Substrate recognition and binding
In simple terms: The enzyme finds the specific uridine in tRNA that needs to be modified.
tRNA dihydrouridine synthases (DUS) recognize their substrate tRNAs through specific structural features, often involving the D-arm and anticodon loop. In Thermus thermophilus, the DUS enzyme specifically binds tRNA and selects uridine residues for modification. The enzyme's active site accommodates the uridine base, positioning it for reduction. Substrate specificity varies among DUS paralogs; for example, human DUS1L targets positions 16 and 17 of tRNA.
Reduction of uridine to dihydrouridine
In simple terms: The enzyme uses a reducing agent to convert uridine into dihydrouridine by saturating a double bond.
The catalytic core of DUS enzymes utilizes a flavin cofactor (FMN or FAD) to transfer electrons from NADPH to the uridine substrate, reducing the C5-C6 double bond and forming dihydrouridine. This reaction is stereospecific and requires an intact active site. In vitro studies with T. thermophilus DUS have demonstrated that the enzyme can catalyze dihydrouridine formation using NADPH as the electron donor. The reaction is sensitive to redox conditions, as shown by differential redox sensitivity of tRNA dihydrouridylation.
Post-catalytic release and tRNA folding
In simple terms: After modification, the tRNA is released and folds into its functional shape.
Once dihydrouridine is formed, the modified tRNA is released from the enzyme. The presence of dihydrouridine introduces a non-planar, saturated ring that increases local flexibility, facilitating proper tRNA folding and stability. This structural change is critical for the tRNA's role in translation. In humans, DUS1L-mediated modification at positions 16/17 affects tRNA stability and translation efficiency.
Functional redundancy and regulation
In simple terms: Multiple enzymes can do the same job, ensuring the modification happens even if one is missing.
In many organisms, multiple DUS paralogs exist with overlapping functions. Studies in yeast and human cells have revealed functional redundancy in tRNA dihydrouridylation, where loss of one DUS can be compensated by others. This redundancy ensures robust modification but complicates genetic analysis. Additionally, the activity of DUS enzymes can be modulated by cellular redox status, linking modification to metabolic state.
Evolutionary diversity and reductive evolution
In simple terms: Some organisms have lost the ability to make dihydrouridine, showing the pathway can be simplified.
While dihydrouridine synthesis is conserved in most organisms, some lineages such as Mollicutes have undergone reductive evolution, losing DUS genes and the modification. This suggests that dihydrouridine is not universally essential, but its loss may have functional consequences. Comparative genomics of DUS enzymes across species provides insights into the evolution of tRNA modification systems.
Key Genes Involved in GO:0002943 tRNA dihydrouridine synthesis
The following genes and proteins are central to tRNA dihydrouridine synthesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DUS1 (yeast) | tRNA dihydrouridine synthase, modifies positions 16/17 | Model for studying DUS function and redundancy |
| DUS2 (yeast) | tRNA dihydrouridine synthase, modifies D-loop | Functional redundancy with DUS1 |
| DUS3 (yeast) | tRNA dihydrouridine synthase, modifies position 47 | Substrate specificity studies |
| DUS4 (yeast) | tRNA dihydrouridine synthase, modifies position 20 | Role in tRNA stability |
| DUS1L (human) | Catalyzes dihydrouridine at tRNA positions 16/17 | Overexpression perturbs translation |
| DUS2 (human) | tRNA dihydrouridine synthase | Implicated in cancer and translation |
| DUS3L (human) | tRNA dihydrouridine synthase | Potential role in mitochondrial tRNA modification |
| DUS4L (human) | tRNA dihydrouridine synthase | Less characterized, possible redundancy |
| TthDUS (Thermus thermophilus) | Thermophilic DUS enzyme | In vitro biochemical assays |
| NADPH | Reducing cofactor for DUS enzymes | Essential for catalytic activity |
| FMN/FAD | Flavin cofactor in DUS active site | Electron transfer during reduction |
| tRNA | Substrate for dihydrouridylation | Structural and functional studies |
| Dihydrouridine (D) | Modified nucleoside product | Marker of tRNA modification status |
| Mollicutes DUS homologs | Reductive evolution of DUS genes | Evolutionary studies |
| Prebiotic uridine | Non-enzymatic dihydrouridine synthesis | Origin of life research |
How Is tRNA dihydrouridine synthesis Regulated?
The process of tRNA dihydrouridine synthesis is regulated at multiple levels. The activity of DUS enzymes is sensitive to cellular redox conditions, as demonstrated by differential redox sensitivity of tRNA dihydrouridylation. This suggests that the modification status of tRNA can respond to oxidative stress and metabolic changes. Additionally, functional redundancy among DUS paralogs provides a buffering mechanism, ensuring that tRNA modification is maintained even when one enzyme is lost. In humans, DUS1L overexpression perturbs translation, indicating that the level of DUS enzyme is critical and must be tightly controlled. However, specific transcriptional or post-translational regulators of DUS genes remain largely uncharacterized, and further research is needed to elucidate the full regulatory network.
tRNA dihydrouridine synthesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DUS1L | Cancer, translational dysregulation | DUS1L overexpression in cancer cell lines |
| DUS2 | Cancer, translation | Knockout in cancer cell lines |
| DUS3L | Mitochondrial disease (hypothesized) | Mitochondrial tRNA modification assays |
| DUS paralogs | Neurological disorders (hypothesized) | Neuronal cell models with DUS knockout |
| Mollicutes DUS | Reductive evolution | Comparative genomics |
Cancer and translational dysregulation
Dysregulation of tRNA modifications, including dihydrouridine synthesis, has been linked to cancer. Human DUS1L overexpression perturbs global translation, which could contribute to oncogenic transformation. Altered tRNA modification profiles are increasingly recognized as hallmarks of cancer, affecting proliferation and stress responses. Targeting DUS enzymes may therefore represent a novel therapeutic strategy.
Neurological disorders
tRNA modifications are critical for neuronal function, and defects in modification enzymes can cause neurological diseases. While direct links between DUS mutations and neurodegeneration are not yet established, the broader class of tRNA modification disorders includes neurodevelopmental phenotypes. The sensitivity of DUS enzymes to redox status may be particularly relevant in neurons, which are highly susceptible to oxidative stress.
Mitochondrial diseases
Mitochondrial tRNAs also undergo dihydrouridylation, and defects in mitochondrial tRNA modification can lead to mitochondrial myopathies and encephalopathies. Human DUS3L is predicted to localize to mitochondria, suggesting a role in mitochondrial tRNA modification. However, experimental evidence linking DUS3L mutations to mitochondrial disease is still lacking, and further studies are needed.
From tRNA dihydrouridine synthesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of DUS? | In vitro enzyme assays with purified DUS and tRNA |
| How does DUS1L overexpression affect translation? | Human cell lines with DUS1L overexpression |
| What is the impact of DUS loss on tRNA modification? | Yeast or human DUS knockout cells |
| How does redox status affect dihydrouridylation? | Cells treated with oxidizing/reducing agents |
| What is the evolutionary conservation of DUS? | Comparative genomics across species |
| Can dihydrouridine be synthesized prebiotically? | Chemical synthesis under prebiotic conditions |
How to Study the tRNA dihydrouridine synthesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression and tRNA modification signatures | Transcriptome-wide effects of DUS perturbation |
| HydraPsiSeq | Dihydrouridine sites at single-nucleotide resolution | Mapping dihydrouridylation in tRNA |
| In vitro DUS assay | Enzymatic activity and kinetics | Biochemical characterization of DUS |
| Mass spectrometry | Nucleoside composition and modification levels | Quantification of dihydrouridine |
| Ribo-seq | Translation efficiency and ribosome occupancy | Impact of DUS1L overexpression on translation |
| Proteomics | Protein expression and interactions | Identifying DUS interaction partners |
| Fluorescence microscopy | Subcellular localization of DUS proteins | Determining organelle-specific modification |
| CRISPR screening | Genes required for dihydrouridylation | Functional genomics of tRNA modification |
RNA sequencing and modification mapping
RNA-seq and specialized modification mapping techniques (e.g., HydraPsiSeq, RiboMethSeq) can detect dihydrouridine at single-nucleotide resolution. These methods rely on the chemical properties of dihydrouridine, which can be selectively derivatized or detected via reverse transcription signatures. Such approaches are essential for quantifying changes in dihydrouridylation upon DUS perturbation.
Biochemical assays for DUS activity
In vitro assays using purified DUS enzymes and synthetic tRNA substrates allow direct measurement of dihydrouridine formation. These assays typically monitor NADPH consumption or use mass spectrometry to detect the modified nucleoside. Thermophilic DUS enzymes, such as that from Thermus thermophilus, are particularly useful due to their stability.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with DUS enzymes, revealing potential regulatory partners. Proteomic profiling of cells with DUS knockout or overexpression can uncover downstream effects on translation and stress responses.
Imaging and cellular localization
Fluorescence microscopy of tagged DUS proteins can reveal their subcellular localization, such as nuclear, cytoplasmic, or mitochondrial distribution. This is important for understanding where dihydrouridylation occurs and how it is regulated.
How CRISPR Can Be Used to Study GO:0002943 tRNA dihydrouridine synthesis
Knockout
CRISPR knockout of DUS genes in cell lines or model organisms can reveal their essentiality and functional redundancy. For example, single knockouts of yeast DUS genes may not show strong phenotypes due to redundancy, but combinatorial knockouts can abolish dihydrouridylation. In human cells, DUS1L knockout can be used to study its specific role in translation.
Point Mutation
Point mutations in the catalytic residues of DUS enzymes can be introduced using CRISPR base editing or homology-directed repair to dissect the enzymatic mechanism. Such mutants can separate catalytic activity from protein-protein interactions, providing insights into DUS function.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous DUS loci allows for affinity purification and localization studies under native expression conditions. This approach avoids artifacts from overexpression and is valuable for studying DUS regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of DUS genes can model the effects of increased dihydrouridylation. Human DUS1L overexpression has been shown to perturb translation, making it a useful tool to study the consequences of hypermodification.
How EDITGENE Supports tRNA dihydrouridine synthesis Research
Researchers studying tRNA dihydrouridine synthesis-related genes often need to determine whether a candidate gene is causally involved in the modification, how it affects translation, and whether its dysregulation contributes to disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for tRNA dihydrouridine synthesis research.
Frequently Asked Questions About tRNA dihydrouridine synthesis
What is tRNA dihydrouridine synthesis?
tRNA dihydrouridine synthesis (GO:0002943) is the biological process where a uridine in tRNA is enzymatically converted to dihydrouridine, a modified nucleoside that affects tRNA structure and function.
What genes are involved in tRNA dihydrouridine synthesis?
The main genes are tRNA dihydrouridine synthases (DUS), including DUS1, DUS2, DUS3, DUS4 in yeast and DUS1L, DUS2, DUS3L, DUS4L in humans.
What is the function of dihydrouridine in tRNA?
Dihydrouridine increases the flexibility of the tRNA D-loop, contributing to proper tRNA folding and stability during translation.
Which enzyme catalyzes dihydrouridine synthesis?
tRNA dihydrouridine synthases (DUS) catalyze the NADPH-dependent reduction of uridine to dihydrouridine.
Is dihydrouridine synthesis conserved across species?
Yes, DUS enzymes are conserved from bacteria to humans, but some organisms like Mollicutes have lost the pathway through reductive evolution.
How does DUS1L overexpression affect translation?
Human DUS1L overexpression perturbs global translation, indicating that precise levels of dihydrouridylation are critical for translational fidelity.
What diseases are linked to tRNA dihydrouridine synthesis?
Dysregulation of tRNA modifications, including dihydrouridylation, has been implicated in cancer and neurological disorders, though direct links are still emerging.
How can I study tRNA dihydrouridine synthesis in the lab?
Common methods include RNA-seq with modification mapping, in vitro DUS activity assays, and CRISPR knockout/overexpression models.
What is the role of redox in dihydrouridylation?
DUS enzyme activity is sensitive to cellular redox status, linking tRNA modification to oxidative stress responses.
Can dihydrouridine be synthesized prebiotically?
Yes, recent studies show that dihydrouridine can form by photoreduction of uridine in formamide under prebiotic conditions.
Conclusion
GO:0002943, tRNA dihydrouridine synthesis, is a fundamental RNA modification process that impacts tRNA structure, translation, and cellular stress responses. The enzymes responsible, DUS proteins, are conserved but exhibit functional redundancy and species-specific adaptations. Dysregulation of this pathway is increasingly linked to human diseases, particularly cancer and neurological disorders. Continued research using CRISPR models and advanced RNA mapping techniques will further elucidate the molecular mechanisms and therapeutic potential of targeting dihydrouridine synthesis.
References
- 1. Finet O et al.. 2022. The Dihydrouridine landscape from tRNA to mRNA: a perspective on synthesis, structural impact and function.. RNA Biol 19(1):735-750 PMID: 35638108
- 2. Kilz LM et al.. 2024. Differential redox sensitivity of tRNA dihydrouridylation.. Nucleic Acids Res 52(21):12784-12797 PMID: 39460624
- 3. Faivre B et al.. 2021. Dihydrouridine synthesis in tRNAs is under reductive evolution in Mollicutes.. RNA Biol 18(12):2278-2289 PMID: 33685366
- 5. Kusuba H et al.. 2015. In vitro dihydrouridine formation by tRNA dihydrouridine synthase from Thermus thermophilus, an extreme-thermophilic eubacterium.. J Biochem 158(6):513-21 PMID: 26112661
- 6. Xu J et al.. 2024. Prebiotic synthesis of dihydrouridine by photoreduction of uridine in formamide.. Chem Commun (Camb) 60(55):7081-7084 PMID: 38896044
- 7. Sudol C et al.. 2024. Functional redundancy in tRNA dihydrouridylation.. Nucleic Acids Res 52(10):5880-5894 PMID: 38682613
- 8. Matsuura J et al.. 2024. Human DUS1L catalyzes dihydrouridine modification at tRNA positions 16/17, and DUS1L overexpression perturbs translation.. Commun Biol 7(1):1238 PMID: 39354220
